BD has expanded a Class I Alaris recall to cover 15 additional pump infusion sets, the company said Friday. The Food and Drug Administration posted the company's notice on Monday. The company added ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

FDA has given Class I status to a Carefusion recall related to the Alaris Model 8100 infusion pump. A software failure in the pump had been identified in modules running software version 9.1.18. Last ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...

WASHINGTON (dpa-AFX) - Becton, Dickinson and Co. or BD (BDX) on Thursday provided an update on two voluntary recalls related to certain Alaris Pump Modules Model 8100 manufactured between April 2011 ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

FDA has assigned a Class I designation to a recall of CareFusion Alaris infusion pumps, originally announced last month. The agency gave the same designation to a recall of frame membranes that Elite ...

CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...

FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...